Launch New Matrix Hydrogel
Amsbio has introduced its new matrix hydrogel – Extragel which is a highly effective growth scaffold for in vivo xenograft generation, pluripotent stem cell maintenance, angiogenesis and advanced 3D culture applications.
Amsbio has recently announced the launch of Extragel, a like-for-like replacement for Matrigel, Geltrex and Cultrex Basement Membrane Extract (BME).
Available ex-stock, with overnight shipment, Extragel is a reconstituted matrix hydrogel formed by basement membrane components extracted from mouse tumor tissues which are rich in extracellular matrix proteins.
Designed to be used undiluted or diluted to a specific protein concentration, Extragel is proven to be a highly effective growth scaffold for in vivo xenograft generation, pluripotent stem cell maintenance / differentiation, angiogenesis and advanced 3D culture applications, shares the company. Extragel is composed of laminin, collagen IV, and heparan sulfate proteoglycans plus various growth factors including epidermal growth factor, platelet-derived growth factor, nerve growth factor, basic fibroblast growth factor (FGF-2), transforming growth factor-β, and insulin-like growth factor.
Formulated to be free of LDEV as well as mycotoxins including fungi, bacteria, and mycoplasma - researchers using Extragel matrix can generate optimized, gels in under 30 minutes at 37 °C. Amsbio implements strict quality inspection to ensure unmatched product stability and high batch-to-batch consistency, concludes the firm.